|
|
1.
|
Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus. MedStar authors:
Year: 2017
Citation: - Clinical Transplantation. 31(5), 2017 May
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Hassan M, Lalos A, Liriano-Ward L, Morales AL, Nair V, Sang M, Satoskar R, Schiano T, Smith C, Tierney A
|
|
|
2.
|
Alcohol-associated liver disease predicts increased post-liver transplant opioid use. MedStar authors:
- Desale, Sameer
- Lalos, Alexander
Year: 2022
Citation: - Clinical Transplantation. :e14811, 2022 Sep 04
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Transplant Hepatology Service
Medline publication type:
All authors: - Desale S, Faust TW, Fernandez S, Fishbein TM, Georgia SJ, Hsu CC, Jenkins ML, Johnson-Laghi KA, Lalos AT, Rangnekar AS, Robertazzi SE, Satoskar RS, Smith CI, Thomas AM, Woo SM, Zafar Z
|
